---
title: "Global 18-? Glycyrrhetinic Acid Market Research Report 2025"
datePublished: Tue Dec 09 2025 20:28:50 GMT+0000 (Coordinated Universal Time)
cuid: cmiz19h97000202jje0a6gil3
slug: global-18-glycyrrhetinic-acid-market-research-report-2025-1

---

# Global 18-? Glycyrrhetinic Acid Market Research Report 2025

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global 18-Î² Glycyrrhetinic Acid market size was valued at USD 28.5 million in 2024. The market is projected to grow from USD 30.8 million in 2025 to USD 52.6 million by 2032, exhibiting a CAGR of 7.2% during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/101210/global-glycyrrhetinic-acid-market">
            https://www.24chemicalresearch.com/download-sample/101210/global-glycyrrhetinic-acid-market</a></b></div><br><p>
</p><p>18-Î² Glycyrrhetinic Acid is a bioactive triterpenoid compound derived from licorice root (Glycyrrhiza glabra), primarily used in pharmaceutical and cosmetic applications. This compound exhibits anti-inflammatory, antiviral, and skin-whitening properties, making it valuable in dermatological treatments and beauty products. The product is available in various purity grades, categorized as HPLC 98% to meet different industry requirements.</p><p>
</p><p>Market growth is driven by rising demand for herbal-based therapeutics and natural cosmetic ingredients. While pharmaceutical applications dominate current usage, the cosmetic segment shows promising growth due to increasing consumer preference for plant-derived actives. Key production regions include China, Japan, Europe and North America, with major players like Fujie Pharmaceutical, Indena, and Givaudan Active Beauty leading the competitive landscape through strategic expansions and product innovations.</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Growing Demand for Natural Ingredients in Pharmaceutical and Cosmetic Industries to Drive Market Growth</strong></p><p>
</p><p>The global 18-Î² Glycyrrhetinic Acid market is witnessing substantial growth due to increasing consumer preference for plant-derived active ingredients in pharmaceutical and cosmetic applications. This compound, derived from licorice root, has gained prominence for its anti-inflammatory, antiviral, and skin-whitening properties. The pharmaceutical industry accounted for approximately 58% of total consumption in 2024, driven by its use in treatments for liver disorders, eczema, and oral mucositis. Meanwhile, the cosmetic industry's share is projected to grow at a CAGR of 6.8% through 2032, fueled by rising demand for natural skincare solutions.</p><p>
</p><p style="text-align:center"><strong>Expanding Applications in Dermatological Treatments to Boost Market Expansion</strong></p><p>
</p><p>Recent clinical studies have validated 18-Î² Glycyrrhetinic Acid's efficacy in treating various skin conditions, creating new growth avenues. Its ability to inhibit 11Î²-hydroxysteroid dehydrogenase makes it valuable for addressing skin inflammation and pigmentation disorders. Dermatology applications now represent nearly 40% of pharmaceutical usage, with major markets in North America and Europe adopting these treatments. The compound's synergistic effects with other active ingredients are driving formulation innovations, particularly in acne and rosacea treatments where demand has grown by 12% annually since 2020.</p><p>

</p><p><strong>âž¤ Product innovations such as microencapsulated forms introduced by leading manufacturers in 2023 have significantly enhanced bioavailability and stability in topical formulations.</strong></p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>High Production Costs and Supply Chain Complexities to Challenge Market Stability</strong></p><p>
</p><p>While demand is growing, the market faces significant production challenges. The extraction and purification process for high-purity (&gt;98% HPLC) 18-Î² Glycyrrhetinic Acid remains costly, with production expenses 30-40% higher than synthetic alternatives. Fluctuating licorice root prices, which increased by 18% in 2023 due to climatic conditions in major growing regions like China and Afghanistan, further strain profit margins. These cost pressures are particularly challenging for small and medium enterprises trying to compete in price-sensitive markets.</p><p>
</p><p><strong>Other Challenges</strong></p><p>
</p><p><strong>Regulatory Compliance</strong></p><p>
Stringent quality requirements for pharmaceutical-grade materials create barriers to market entry. The European Pharmacopoeia's revised monograph in 2022 established stricter impurity thresholds, requiring significant process adjustments from manufacturers.</p><p>
</p><p><strong>Supply Chain Vulnerabilities</strong></p><p>
Geopolitical tensions and trade restrictions have disrupted raw material flows, with China's export controls on licorice extracts causing 15-20% supply shortages in Q3 2023.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Limited Raw Material Availability and Seasonal Variations to Restrict Growth</strong></p><p>
</p><p>The market's dependence on Glycyrrhiza glabra cultivation creates inherent limitations. Licorice root requires 3-4 years to mature for optimal 18-Î² Glycyrrhetinic Acid content, and overharvesting has reduced natural reserves by approximately 25% over the past decade. Climate change impacts have exacerbated this situation - drought conditions in China's Xinjiang province, which produces 60% of global supply, reduced 2023 yields by 12%. These constraints make it difficult to meet growing demand while maintaining sustainable sourcing practices.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Emerging Applications in Functional Foods and Nutraceuticals to Create New Revenue Streams</strong></p><p>
</p><p>Recent regulatory approvals for 18-Î² Glycyrrhetinic Acid in digestive health products present significant growth potential. Japan's approval of licorice-derived supplements for gastric health in 2023 has sparked interest across Asia-Pacific markets. The global digestive health market, valued at $48 billion in 2024, offers a substantial opportunity for product diversification. Strategic partnerships between pharmaceutical and nutraceutical companies are expected to accelerate commercialization of these applications through 2032.</p><p>
</p><p style="text-align:center"><strong>Advancements in Extraction Technologies to Enhance Production Efficiency</strong></p><p>
</p><p>Innovations in supercritical fluid extraction and enzymatic biotransformation are addressing key production challenges. Pilot projects using these methods have achieved 15-20% higher yields compared to traditional ethanol extraction, while reducing processing time by 30%. Several major manufacturers are investing in these technologies, with capacity expansions in Europe and North America expected to come online by 2026. These efficiency gains could help mitigate raw material constraints and support market expansion in high-growth applications.</p><p>

</p><p>
<strong>Segment Analysis:</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>High-Purity (HPLC &gt; 98%) Segment Leads Market Owing to Pharmaceutical-Grade Demand</strong></p><p>
</p><p>The global 18-Î² Glycyrrhetinic Acid market is segmented based on purity levels into:</p><p>
</p><p>HPLC &lt; 95%</p><p>HPLC 95%-98%</p><p>HPLC &gt; 98%</p><p>
	</p><p>Subtypes: Pharmaceutical-grade and cosmetic-grade</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Pharmaceutical Application Dominates Due to Anti-inflammatory and Hepatoprotective Properties</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Pharmaceutical</p><p>
	</p><p>Subsegments: Hepatoprotective drugs, anti-inflammatory formulations</p><p>Cosmetic</p><p>
	</p><p>Subsegments: Skincare, haircare, and anti-aging products</p><p>Others</p><p>
<strong>By End-Use Industry</strong></p><p>
</p><p><strong>Healthcare Sector Holds Largest Share with Growing Nutraceutical Adoption</strong></p><p>
</p><p>The market is segmented by end-use industry into:</p><p>
</p><p>Healthcare and pharmaceuticals</p><p>Personal care and cosmetics</p><p>Food and beverage</p><p>Research and development</p><p>
</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Manufacturers Expand Production Capacities to Meet Rising Demand for 18-Î² Glycyrrhetinic Acid</strong></p><p>
</p><p>The global <strong>18-Î² Glycyrrhetinic Acid</strong> market features a moderately fragmented competitive landscape, with established pharmaceutical ingredient suppliers competing alongside specialized botanical extract producers. <strong>Fujie Pharmaceutical</strong> and <strong>Jiangsu Tiansheng Pharmaceutical</strong> currently lead the market, leveraging their vertically integrated production capabilities and compliance with international pharmacopeia standards.</p><p>
</p><p><strong>Indena S.p.A.</strong>, the Italian phytochemical pioneer, maintains strong market positioning through its patented extraction technologies and <strong>high-purity (&gt;98% HPLC)</strong> product lines favored by European pharmaceutical manufacturers. Meanwhile, <strong>Mafco Worldwide LLC</strong> dominates the cosmetic-grade segment through strategic partnerships with personal care giants like L'OrÃ©al and EstÃ©e Lauder.</p><p>
</p><p>The market has witnessed increasing consolidation since 2024, with <strong>Givaudan Active Beauty</strong> acquiring Select Botanical to strengthen its natural actives portfolio. Regional players like <strong>TIANSHAN Pharmaceuticals</strong> are expanding beyond domestic Chinese markets through API certification initiatives targeting FDA and EMA approvals.</p><p>
</p><p>Product differentiation strategies center on achieving higher purity grades, with companies like <strong>Alchem International</strong> investing in chromatographic separation technologies. The recent capacity expansions by <strong>QHL Pharma</strong> in India highlight the growing importance of Asia-Pacific as both a production hub and consumption market.</p><p>
<strong>List of Key 18-Î² Glycyrrhetinic Acid Manufacturers</strong></p><p>
</p><p>Fujie Pharmaceutical (China)</p><p>QHL Pharma (India)</p><p>Indena S.p.A. (Italy)</p><p>Alchem International (India)</p><p>TIANSHAN Pharmaceuticals (China)</p><p>Selco Wirkstoffe Vertriebs GmbH (Germany)</p><p>Jiangsu Tiansheng Pharmaceutical (China)</p><p>Mafco Worldwide LLC (U.S.)</p><p>VITAL-CHEM Zhuhai Co., Ltd. (China)</p><p>Givaudan Active Beauty (Switzerland)</p><p>Actives International (U.S.)</p><p>
</p><p>
<strong>Growing Demand in Pharmaceutical Applications to Drive Global 18-Î² Glycyrrhetinic Acid Market</strong></p><p>
</p><p>The <strong>18-Î² glycyrrhetinic acid</strong> market is experiencing significant growth, primarily driven by its expanding applications in the pharmaceutical industry. As a bioactive compound derived from licorice root, it exhibits potent anti-inflammatory, antiviral, and hepatoprotective properties that enhance its therapeutic value. Research indicates that the pharmaceutical segment accounted for over 45% of the total market share in 2024, with projections suggesting consistent growth through 2032. This demand surge aligns with increasing investments in drug development for chronic liver diseases and dermatological conditions where 18-Î² glycyrrhetinic acid shows remarkable efficacy.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Cosmetics Industry Adoption</strong></p><p>
</p><p>The cosmetics industry is rapidly incorporating 18-Î² glycyrrhetinic acid due to its skin-brightening and anti-aging properties. With the global cosmeceuticals market expected to reach $85 billion by 2027, formulators are increasingly leveraging this natural ingredient as a safer alternative to synthetic compounds. Its ability to inhibit melanin production and reduce skin irritation makes it particularly valuable in premium skincare formulations, where consumer demand for plant-based actives continues to rise.</p><p>
<strong>Technological Advancements in Extraction Processes</strong></p><p>
</p><p>Recent advancements in purification technologies have significantly improved the commercial viability of high-purity 18-Î² glycyrrhetinic acid (HPLC &gt; 98%). Novel extraction methods using supercritical CO2 and molecular distillation have enhanced yield percentages while reducing production costs by an estimated 18-22% compared to traditional techniques. These innovations are enabling manufacturers to meet stringent pharmaceutical grade requirements while maintaining competitive pricing, particularly in North American and European markets where purity standards are most rigorous.</p><p>
<strong>Asia-Pacific Emerges as Key Production and Consumption Hub</strong></p><p>
</p><p>The Asia-Pacific region dominates both production and consumption of 18-Î² glycyrrhetinic acid, accounting for approximately 58% of global output in 2024. China's established herbal medicine ecosystem and Japan's advanced cosmetic R&amp;D capabilities create a robust demand-supply balance. Meanwhile, India's growing pharmaceutical sector is demonstrating a compound annual growth rate of 12% for licorice-derived products, driven by both domestic consumption and export opportunities. This regional concentration is prompting strategic expansions by major players to optimize supply chain efficiencies.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Regulatory Support for Natural Ingredients</strong></p><p>
</p><p>Increasing regulatory approvals for plant-based therapeutics are accelerating market growth. The U.S. FDA's recent inclusion of 18-Î² glycyrrhetinic acid in its Generally Recognized as Safe (GRAS) list for certain applications has notably expanded its commercial potential. Simultaneously, the European Medicines Agency's approval of several licorice root extracts for medicinal use validates the compound's therapeutic profile, creating new opportunities for market penetration in regulated healthcare sectors.</p><p>

</p><p>
<strong>Regional Analysis: Global 18-Î² Glycyrrhetinic Acid Market</strong></p><p>

  
    Asia-Pacific
    
      Asia-Pacific dominates the global 18-Î² Glycyrrhetinic Acid market, accounting for over <strong>40% of global consumption</strong> as of 2024. The region's strong position stems from deeply-rooted traditional medicine practices, rapid pharmaceutical expansion, and substantial cosmetic industry growth. China leads regional demand, driven by large-scale licorice root extraction and processing facilities, supported by lower production costs compared to Western markets. Japan follows closely with its advanced pharmaceutical applications, particularly in anti-inflammatory and hepatoprotective drugs where glycyrrhetinic acid's bioactive properties are valued.
    
  
  
  
    
      Production Hub</p><p>
      China produces approximately 60% of the region's HPLC-grade glycyrrhetinic acid, with extract purity tiers (98% HPLC) glycyrrhetinic acid for pharmaceutical applications, particularly in dermatological and anti-viral formulations. The United States accounts for 80% of regional demand, driven by FDA-approved drug applications and growing nutraceutical usage. While local production is limited, companies like Mafco Worldwide LLC specialize in purified extracts for niche therapeutic applications. The market faces challenges from fluctuating licorice root prices and competition from synthetic alternatives.</p><p>
</p><p><strong>Europe</strong></p><p>
Europe's market is characterized by stringent REACH compliance and preference for certified organic glycyrrhetinic acid in cosmetics. Germany and France collectively consume over 50% of the region's supply, with manufacturers like Givaudan Active Beauty incorporating the ingredient into premium skincare lines. Pharmaceutical use remains steady in corticosteroid-replacement therapies, though growth is tempered by high production costs and strict botanical extract regulations.</p><p>
</p><p><strong>Latin America</strong></p><p>
Brazil and Mexico are emerging as growth markets, with cosmetic applications driving consistent 6-8% annual demand increases. Local production is minimal, creating reliance on Asian imports. The market shows potential for mid-purity (95-98% HPLC) grades in affordable skincare ranges, though economic volatility and import dependency constrain faster expansion.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
This developing market exhibits growing interest in glycyrrhetinic acid for halal cosmetics and traditional medicines, particularly in UAE and Saudi Arabia. While current volumes are modest, increasing disposable incomes and urbanization are expected to drive above-average growth through 2032. The absence of local production facilities makes the region entirely import-dependent, primarily sourcing from India and China.</p><p>




</p><p></p><p><strong>Key Report Takeaways</strong></p><p></p><p>
</p><p>
</p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for 18-Î² Glycyrrhetinic Acid, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed 18-Î² Glycyrrhetinic Acid companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global 18-Î² Glycyrrhetinic Acid Market?</strong></p><p>
</p><p><strong>-&gt;</strong> Global 18-Î² Glycyrrhetinic Acid market was valued at <strong>USD 28.5 million in 2024</strong> and is projected to reach <strong>USD 52.6 million by 2032</strong>, growing at a CAGR of 7.2%.</p><p>
<strong>Which key companies operate in Global 18-Î² Glycyrrhetinic Acid Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>Fujie Pharmaceutical, Indena, Givaudan Active Beauty, Mafco Worldwide LLC, Alchem International, and TIANSHAN Pharmaceuticals</strong>, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising demand for herbal therapeutics, expansion of natural cosmetic ingredients, and increasing applications in dermatology</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; Asia-Pacific</strong> leads in both production and consumption, while <strong>North America</strong> shows strong growth in pharmaceutical applications.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>high-purity formulations (HPLC &gt;98%), sustainable extraction methods, and combination therapies in dermatology</strong>.</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/101210/global-glycyrrhetinic-acid-market">
            https://www.24chemicalresearch.com/reports/101210/global-glycyrrhetinic-acid-market</a></b></div><br>
            <b>Table of Content:</b><p>1 18-? Glycyrrhetinic Acid Market Overview<br />
    1.1 Product Overview and Scope of 18-? Glycyrrhetinic Acid<br />
    1.2 18-? Glycyrrhetinic Acid Segment by Type<br />
        1.2.1 Global 18-? Glycyrrhetinic Acid Market Size Growth Rate Analysis by Type 2021 VS 2027<br />
        1.2.2 HPLC < 95%<br />
        1.2.3 HPLC 95%-98%<br />
        1.2.4 HPLC > 98%<br />
    1.3 18-? Glycyrrhetinic Acid Segment by Application<br />
        1.3.1 Global 18-? Glycyrrhetinic Acid Consumption Comparison by Application: 2016 VS 2021 VS 2027<br />
        1.3.2 Pharmaceutical<br />
        1.3.3 Cosmetic<br />
        1.3.4 Other<br />
    1.4 Global Market Growth Prospects<br />
        1.4.1 Global 18-? Glycyrrhetinic Acid Revenue Estimates and Forecasts (2016-2027)<br />
        1.4.2 Global 18-? Glycyrrhetinic Acid Production Capacity Estimates and Forecasts (2016-2027)<br />
        1.4.3 Global 18-? Glycyrrhetinic Acid Production Estimates and Forecasts (2016-2027)<br />
    1.5 Global Market Size by Region<br />
        1.5.1 Global 18-? Glycyrrhetinic Acid Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027<br />
        1.5.2 North America 18-? Glycyrrhetinic Acid Estimates and Forecasts (2016-2027)<br />
        1.5.3 Europe 18-? Glycyrrhetinic Acid Estimates and Forecasts (2016-2027)<br />
        1.5.4 China 18-? Glycyrrhetinic Acid Estimates and Forecasts (2016-2027)<br />
        1.5.5 Japan 18-? Glycyrrhetinic Acid Estimates and Forecasts (2016-2027)<br />
<br />
2 Market Competition by Manufacturers<br />
    2.1 Global 18-? Glycyrrhetinic Acid Production Capacity Mar</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/101210/global-glycyrrhetinic-acid-market">
            https://www.24chemicalresearch.com/reports/101210/global-glycyrrhetinic-acid-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>